Product Information
VENLAFAXINE HCL 50 MG TABLET is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.0979 per EA under NDC 62332001031. Its NADAC has been published 538 times since Mar 9, 2016.
Strength
50 mg/1
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332001031
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
VENLAFAXINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA078932On Market Since
10/1/2015
Pharmacological Classes
Price Statistics
The NADAC for VENLAFAXINE HCL 50 MG TABLET has been published 538 times since Mar 9, 2016, and over the history we have for it it has declined 68.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0979 per EA |
|---|---|
| All-time high | $0.3839 (Dec 14, 2016) |
| All-time low | $0.0537 (Jan 18, 2023) |
| 52-week high | $0.0979 |
| 52-week low | $0.0797 |
| Median price | $0.1675 |
| Average price | $0.1723 |
| Largest weekly change | +66.0% (Jun 19, 2024) |
| Weeks tracked | 538 |
| Tracking since | Mar 9, 2016 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the venlafaxine market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of VENLAFAXINE HCL 50 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for VENLAFAXINE HCL 50 MG TABLET, manufactured by Alembic Pharmaceuticals Inc., is $0.0979 per EA (NDC 62332001031), effective Jun 24, 2026.
How has the price of VENLAFAXINE HCL 50 MG TABLET changed over time?
Over the history we have for it, the NADAC for VENLAFAXINE HCL 50 MG TABLET has declined 68.8%. It has been tracked across 538 weekly CMS publications since Mar 9, 2016.
What are the highest and lowest recorded NADAC prices for VENLAFAXINE HCL 50 MG TABLET?
Since Mar 9, 2016, the NADAC for VENLAFAXINE HCL 50 MG TABLET has ranged from a low of $0.0537 (Jan 18, 2023) to a high of $0.3839 (Dec 14, 2016), with a median of $0.1675 per EA.
Are there cheaper alternatives to VENLAFAXINE HCL 50 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of VENLAFAXINE HCL 50 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures VENLAFAXINE HCL 50 MG TABLET?
VENLAFAXINE HCL 50 MG TABLET (NDC 62332001031) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification